In December 2024, the Bipartisan Artificial Intelligence (AI) Task Force released the “Bipartisan House Task Force Report on Artificial Intelligence.”…
The 119th, Congress faces critical policy decisions to address rising federal deficits, which are projected by the Congressional Budget Office…
The U.S. Drug Enforcement Administration (DEA) has extended the temporary telemedicine flexibilities allowing providers to prescribe controlled substances without an…
The Coalition for Health AI (CHAI), a group of stakeholders that collaborate to drive the development, evaluation, and appropriate use…
On November 8, 2024, Aimed Alliance submitted feedback to the Maryland Prescription Drug Affordability Board regarding its updated rules for…
Currently, Medicare coverage for anti-obesity medications is limited to indications for diabetes and cardiovascular disease. Policymakers, however, have proposed expanding…
On October 10, 2024, the National AI Advisory Committee released its draft transition plan for the incoming administration. The…
A recent survey by the National Community Pharmacists Association (NCPA) indicates that over 90 percent of independent pharmacies may choose…
A recent survey of 227 patients examining patients’ experiences with alternative funding programs (AFP) found that most patients subject to…
Join Aimed Alliance and HR.com for an upcoming webinar on December 4, 2024 at 3PM ET. Menopause and perimenopause are…